| Solid Neoplasm studied in …STUDIED_INderived200 of 6,088show all (up to 200) |
|---|
| → studied in | NCT00591383Phase 1 · completed Phase I Study of Indibulin in Combination With Erlotinib in Advanced Solid Tumors · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00592163Phase 1 · completed Phase I Study of Oral ZIO-101-C in Advanced Solid Tumors and Lymphomas · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00726687Phase 1/Phase 2 · completed Phase 1b Study of Indibulin in Combination With Capecitabine in Advanced Solid Tumors · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01340547Phase 1 · completed Effect on QTc, Pharmacokinetics, Safety, and Preliminary Efficacy of Single-agent Palifosfamide-tris in Subjects With Advanced Solid Tumors · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02465060Phase 2 · active not recruiting Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial) · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Malignant Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02498912Phase 1 · active not recruiting Cyclophosphamide Followed by Intravenous and Intraperitoneal Infusion of Autologous T Cells Genetically Engineered to Secrete IL-12 and to Target the MUC16ecto Antigen in Patients With Recurrent MUC16ecto+ Solid Tumors · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03707808Phase 1/Phase 2 · active not recruiting Intratumoral Injection of Autologous CD1c (BDCA-1)+ myDC, AS01B, and Ipilimumab Plus Systemic Nivolumab · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03837899Phase 1/Phase 2 · active not recruiting Durvalumab and Tremelimumab for Pediatric Malignancies · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03842228Phase 1 · active not recruiting Testing the Combination of the Anti-cancer Drugs Copanlisib, Olaparib, and MEDI4736 (Durvalumab) in Patients With Advanced Solid Tumors With Selected Mutations · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Malignant Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04111458Phase 1 · active not recruiting A Study to Test Different Doses of BI 1701963 Alone and Combined With Trametinib in Patients With Different Types of Advanced Cancer (Solid Tumours With KRAS Mutation) · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04438382Phase 2 · terminated Infliximab and Intravenous Immunoglobulin Therapy in Treating Patients With Steroid-Refractory Pneumonitis · condition mapped ONTOLOGY_EXACT · 6,088 trials mapped (1,991 active) | — | — | Malignant Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04888988NA · active not recruiting Testing the Effects of Exercise on Chemotherapy-Induced Peripheral Neuropathy · condition mapped ONTOLOGY_EXACT · 6,088 trials mapped (1,991 active) | — | — | Malignant Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05390827recruiting Remote Digital Physiologic Data Collection in Cancer: An MSK Registry Protocol · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05564377Phase 2 · recruiting Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Malignant Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05731271Phase 1/Phase 2 · active not recruiting A First-in-Human, Phase 1 Study of TST003 in Subjects With Solid Tumors · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05741242Phase 1/Phase 2 · enrolling by invitation A Phase 1b/2, Multi-center, Single Arm Study to Assess the Safety and Efficacy of Neoantigen Synthetic Long Peptide Vaccines in Patients With Local Or Metastatic Solid Tumors · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05803382Phase 1 · recruiting Testing the Addition of an Anti-Cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment (Capecitabine) for Metastatic or Unresectable Cancers · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Malignant Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05875168Phase 1/Phase 2 · recruiting First-in-Human Study of DS-3939a in Participants With Advanced Solid Tumors · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06098651Phase 1 · completed A Study of DCR-STAT3 in Adults With Solid Tumors · condition mapped ALIAS · 6,088 trials mapped (1,991 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06581432Phase 2 · recruiting Beamion PANTUMOR-1: A Study to Test Whether Zongertinib Helps People With Advanced Cancers With HER2 Alterations · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06619509Phase 2 · active not recruiting A Study to Test Long-term Treatment With Brigimadlin in People With Solid Tumours Who Took Part in a Previous Study With This Medicine · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06799065Phase 1/Phase 2 · recruiting First-in-Human Study of ATX-295, an Oral Inhibitor of KIF18A, as Monotherapy and in Combination With Anticancer Therapy in Patients With Advanced or Metastatic Solid Tumors, Including Ovarian Cancer · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07030959Phase 1 · recruiting Study of AUBE00 in Patients With Solid Tumors · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07127874Phase 1 · recruiting A Study of PHN-012 in Patients With Advanced Solid Tumors · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07224425Phase 1 · recruiting A Study of BI 3810944 in Patients With Advanced Cancer · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07360314Phase 1 · recruiting Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07489378recruiting NCI Childhood Cancer Data Initiative (CCDI) Led Pediatric, Adolescent, and Young Adult Rare Cancer Registry for Very Rare Solid Tumors · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07509034Phase 1 · recruiting Autologous B7-H3 Chimeric Antigen Receptor T Cells in Previously Treated Extensive-Stage Small Cell Lung Cancer With Recurrent or Refractory Disease · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07607678Phase 1 · recruiting A Study in People With Advanced Cancer to Test How Well Different Doses of BI 3819026 Are Tolerated When Taken Alone and Together With Ezabenlimab · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Malignant Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07819136Phase 1/Phase 2 · recruiting REC-7735 in Participants With Solid Tumors · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07847281Phase 1 · not yet recruiting A Study of AK157D1 for Injection in Advanced Solid Tumors · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02379416Phase 1 · completed Combination Nilotinib and Paclitaxel in Adults With Relapsed Solid Tumors · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03994796Phase 2 · active not recruiting Genetic Testing in Guiding Treatment for Patients With Brain Metastases · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Malignant Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04442425completed Machine Learning to Analyze Facial Imaging, Voice and Spoken Language for the Capture and Classification of Cancer/Tumor Pain · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05048368Phase 1 · withdrawn Pharmacokinetics Study of Larotinib in Subjects With Impaired Hepatic Function · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05103358Phase 2 · completed Phase 2 Basket Trial of Nab-sirolimus in Patients With Malignant Solid Tumors With Pathogenic Alterations in TSC1/TSC2 Genes (PRECISION 1) · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05867251Phase 1/Phase 2 · recruiting Study of AVZO-021 in Patients With Advanced Solid Tumors · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05981703Phase 1 · recruiting A Study Investigating BGB-26808 Alone or in Combination With Tislelizumab in Participants With Advanced Solid Tumors · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06120283Phase 1 · recruiting BGB-43395 Alone or as Part of Combination Therapies in Participants With Breast Cancer and Other Advanced Solid Tumors · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06384807Phase 1/Phase 2 · recruiting A Phase 1/2 Study of BHV-1510 (Previously PBI-410) in Advanced Solid Tumors · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06470971Phase 2 · recruiting Siltuximab for the Prevention of Severe Immune-Related Adverse Events During Immune Checkpoint Inhibitor Rechallenge in Patients With Advanced Cancer, CIRES Trial · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Malignant Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06586957Phase 1 · recruiting A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07181681Phase 1 · recruiting A First-in-Human Study of BG-C0902 Alone and in Combination With Other Therapeutic Agents in Patients With Advanced Solid Tumors · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07222267Phase 1 · recruiting An Investigational Study of BG-75202 Alone and in Combination With Other Therapeutic Agents in Adults With Advanced Solid Tumors · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07226349Phase 1 · recruiting A Study of BG-75098 Alone and in Combination With Other Agents in Adults With Advanced Solid Tumors · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07293754Phase 1/Phase 2 · recruiting An Early Phase Trial of RPTR-1-201 in Advanced Solid Tumors · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Malignant Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07414836Phase 1 · recruiting A First-in-Human Study of BG-C0979 in Adults With Advanced Solid Tumors · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07601334Phase 1 · recruiting Safety and Activity of HF50 in Patients With Advanced Solid Tumors · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07737314NA · not yet recruiting Tele-HOPE: A Telehealth Pharmacist Opioid Patient Education Pilot Study · condition mapped ONTOLOGY_EXACT · 6,088 trials mapped (1,991 active) | — | — | Malignant Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07843550Phase 1/Phase 2 · not yet recruiting A Phase 1/2 Trial Of Larotrectinib And Pembrolizumab In Patients With Solid Tumors Previously Treated With Immune Checkpoint Inhibitor Monotherapy · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07844447Phase 1/Phase 2 · not yet recruiting A Study of RT036 in Patients With Advanced Solid Tumors · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Malignant Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02389309Phase 1 · active not recruiting Dasatinib, Temsirolimus, and Cyclophosphamide in Treating Patients With Advanced, Recurrent, or Refractory Solid Tumors · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Malignant Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02498613Phase 2 · active not recruiting A Phase 2 Study of Cediranib in Combination With Olaparib in Advanced Solid Tumors · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Malignant Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02595931Phase 1 · active not recruiting M6620 and Irinotecan Hydrochloride in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Malignant Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03568656Phase 1/Phase 2 · completed Study to Evaluate CCS1477 in Advanced Tumours · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04094610Phase 1/Phase 2 · recruiting A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04170075NA · completed Whole Body Vibration for the Improvement of Health and Functioning in Participants With Chemotherapy-Induced Peripheral Neuropathy · condition mapped ONTOLOGY_EXACT · 6,088 trials mapped (1,991 active) | — | — | Malignant Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04981119recruiting Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing · condition mapped ALIAS · 6,088 trials mapped (1,991 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05059678NA · recruiting Parenting Support Intervention for Families Coping With Metastatic or Locally Recurrent Solid Tumor Diagnosis · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Malignant Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05327010Phase 2 · active not recruiting Testing the Combination of the Anti-cancer Drugs ZEN003694 (ZEN-3694) and Talazoparib in Patients With Advanced Solid Tumors, The ComBET Trial · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Malignant Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05605496Phase 2 · active not recruiting NP137 Clinical and Biological Activities Assessment in Patients With Advanced/Metastatic Solid Tumors Treated by Standard Anti PD-1/PD-L1 Immunotherapies · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05629689Phase 1 · terminated A Study to Evaluate GEH200520/GEH200521 (18F) Safety and Tolerability When Used for PET Scans in Patients With Solid Tumour Malignancies · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Malignant Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05647122Phase 1 · active not recruiting First in Human Study of AZD9592 in Solid Tumors · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06004245Phase 1 · recruiting A Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of VVD-133214 as Monotherapy and in Combination in Participants With Advanced Solid Tumors · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06106360active not recruiting A Pilot Prospective Clinical Trial Using Remote Monitoring for Cancer Patients Undergoing Outpatient Chemotherapy · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06172478Phase 2 · recruiting A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06178614Phase 1 · recruiting A Study of JNJ-87890387 for Advanced Solid Tumors · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06218914Phase 1 · recruiting Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors · condition mapped ALIAS · 6,088 trials mapped (1,991 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06224855Phase 1 · recruiting A Study of DXC006 in Patients With Advanced Solid Tumors and Hematologic Malignancies · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06349408Phase 1 · recruiting IBI3001 in Participants With Unresectable, Locally Advanced or Metastatic Solid Tumors · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06383598NA · completed PD-L1 Specific [68Ga]Ga-THP-PDL1-3 Probe for PET Imaging in Solid Tumors · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06441331Phase 1 · recruiting Phase I Trial to Determine the Dose and Evaluate the PK and Safety of Lutetium Lu 177 Edotreotide Therapy in Pediatric Participants With SSTR-positive Tumors · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06788509Phase 1 · enrolling by invitation A Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring · condition mapped ALIAS · 6,088 trials mapped (1,991 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06855524Phase 2 · recruiting Fucoidan for Preventing Chemotherapy-Related Fatigue in Patients With Gastrointestinal, Gynecological, Breast, or Lung Cancer · condition mapped ONTOLOGY_EXACT · 6,088 trials mapped (1,991 active) | — | — | Malignant Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06963281Phase 1 · recruiting Study of IBI3020 Treatment in Participants With Late-Stage Solid Tumors · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07841925Phase 1/Phase 2 · not yet recruiting A Study of BL-M08D in Patients With Locally Advanced or Metastatic Melanoma and Other Solid Tumors · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07842445Phase 1 · not yet recruiting Phase 1a/1b Clinical Trials to Evaluate the Safety and Preliminary Efficacy of GNTbm-38. · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01775072recruiting Genomic Profiling in Cancer Patients · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02293954NA · active not recruiting Copper Cu 64 Anti-CEA Monoclonal Antibody M5A PET in Diagnosing Patients With CEA Positive Cancer · condition mapped ALIAS · 6,088 trials mapped (1,991 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04306224Phase 1 · completed A Study of IMC-002 in Subjects With Metastatic or Locally Advanced Solid Tumors and Relapsed or Refractory Lymphomas · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05118789Phase 1/Phase 2 · recruiting A Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1) · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06660654Phase 2 · active not recruiting A Study of Raludotatug Deruxtecan in Participants With Advanced/Metastatic Solid Tumors (REJOICE-PanTumor01) · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06824155early Phase 1 · recruiting HEAT Trial (HER2 Antibody Therapy With Lutetium-177) · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06911008Phase 1 · recruiting MTI-301 for the Treatment of Metastatic or Unresectable and Refractory Solid Cancers · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Malignant Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07391670Phase 1 · recruiting A Phase I Dose Escalation and Dose Expansion Study to Investigate the Pharmacokinetics and Safety of Subcutaneous Durvalumab · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07824934Phase 1 · recruiting HEC-921 Injection as Monotherapy and in Combination With Antineoplastic Therapies in Patients With Advanced Malignant Solid Tumors · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Malignant Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07839819Phase 1/Phase 2 · not yet recruiting Study of PM54 in Combination With Cytotoxic and Targeted Agents in Adult Participants With Advanced Malignancies · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02650401Phase 1/Phase 2 · active not recruiting Study Of Entrectinib (Rxdx-101) in Children and Adolescents With Locally Advanced Or Metastatic Solid Or Primary CNS Tumors And/Or Who Have No Satisfactory Treatment Options · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03340506Phase 4 · recruiting Dabrafenib and/or Trametinib Rollover Study · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03816345Phase 1 · recruiting Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO · condition mapped ONTOLOGY_EXACT · 6,088 trials mapped (1,991 active) | — | — | Malignant Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04222413Phase 1 · recruiting Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06009926Phase 2 · active not recruiting Evaluation of Broccoli Seed and Sprout Extract for Detoxification of Carcinogens in Firefighters · condition mapped ONTOLOGY_EXACT · 6,088 trials mapped (1,991 active) | — | — | Malignant Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06088004Phase 1/Phase 2 · recruiting Phase Ⅰ/Ⅱ Clinical Study to Evaluate ABO2011 in Advanced Solid Tumors · condition mapped ALIAS · 6,088 trials mapped (1,991 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06126276Phase 2 · recruiting Testing the Use of Neratinib or the Combination of Neratinib and Palbociclib Targeted Treatment for HER2+ Solid Tumors (A ComboMATCH Treatment Trial) · condition mapped ONTOLOGY_EXACT · 6,088 trials mapped (1,991 active) | — | — | Malignant Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06253520Phase 1 · active not recruiting Autologous T-cells Genetically Engineered to Express Receptors Reactive Against KRAS Mutations in Conjunction With a Vaccine Directed Against These Antigens in Participants With Metastatic Cancer · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Malignant Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06302621Phase 1 · recruiting Pemigatinib + Afatinib in Advanced Refractory Solid Tumors · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06587100recruiting Wearable Activity Tracking to Curb Hospitalizations · condition mapped ONTOLOGY_EXACT · 6,088 trials mapped (1,991 active) | — | — | Malignant Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06619587Phase 1 · recruiting A Study to Evaluate Safety, Pharmacokinetics, and Activity of GDC-7035 as a Single Agent and in Combination in Patients With Advanced Solid Tumors · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06629584Phase 2 · recruiting Phase II Study of Asciminib for Second-line Treatment of Chronic Phase Chronic Myeloid Leukemia · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Malignant Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06915753Phase 1 · recruiting Safety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway Aberrations · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07136142Phase 1/Phase 2 · recruiting A Phase I/II Clinical Study of FH-006 for Injection in Patients With Malignant Solid Tumors · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Malignant Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07537881Phase 1/Phase 2 · recruiting A I/II Phase Clinical Study to Evaluate the Safety and Efficacy of RC288 in the Treatment of Solid Tumors · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07800936Phase 1 · recruiting HP007 Monotherapy for Relapsed or Refractory Advanced Solid Tumors · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07835841NA · not yet recruiting Blessing Stem Cells to Improve Spiritual Well Being and Quality of Life for Patients Undergoing Hematopoietic Stem Cell Transplantation · condition mapped ONTOLOGY_EXACT · 6,088 trials mapped (1,991 active) | — | — | Malignant Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07836036Phase 1 · not yet recruiting Evaluation of RAS Inhibitor Treatment in Participants With Advanced or Metastatic Solid Tumors Harboring RAS Mutations · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07837505not yet recruiting Integrating Geriatric 8 (G8) Screening and Cancer and Age Research Group (CARG) Toxicity Assessment Score Into Routine Care for Older Adults With Cancer · condition mapped ONTOLOGY_EXACT · 6,088 trials mapped (1,991 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07837622Phase 2 · not yet recruiting A Study of BL-M09D1 in Patients With Locally Advanced or Metastatic Urothelial Carcinoma and Other Solid Tumors · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02423057Phase 1 · completed Phase I Trial of 4'-Thio-2'-Deoxycytidine (TdCyd) in Patients With Advanced Solid Tumors · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02693535Phase 2 · recruiting TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03210714Phase 2 · active not recruiting Erdafitinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With FGFR Mutations (A Pediatric MATCH Treatment Trial) · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Malignant Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03366116Phase 1 · recruiting 5-aza-4'-Thio-2'-Deoxycytidine (Aza-TdC) in People With Advanced Solid Tumors · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03815643Phase 3 · active not recruiting Avelumab Program Rollover Study · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04221204Phase 1 · completed A Monotherapy in Subjects With Advanced Solid Tumors · condition mapped ALIAS · 6,088 trials mapped (1,991 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04855656Phase 1 · recruiting Study of Lunresertib Alone or in Combination With RP-3500 or Debio 0123 in Patients With Advanced Solid Tumors · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05477784NA · terminated Cancer Parenting Program for the Enhancement of the Quality of Life of Patients With Advanced Cancer and Their Children · condition mapped ONTOLOGY_EXACT · 6,088 trials mapped (1,991 active) | — | — | Malignant Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05564806Phase 1 · completed Study of YH004 (4-1BB Agonist Antibody) in Advanced Solid Tumors And Relapsed Or Refractory Non-Hodgkin Lymphoma · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06641908Phase 1 · recruiting Anti-GD2 ADC M3554 in Advanced Solid Tumors · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06714617Phase 1 · terminated Evaluate BL-M17D1 in Patients w/HER2-Expressing/Mutant Advanced or Metastatic Solid Tumors · condition mapped ALIAS · 6,088 trials mapped (1,991 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06771219Phase 1 · recruiting SLV-154 Treatment of Advanced Cancers · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07228247Phase 1/Phase 2 · recruiting A Phase Ⅰ/Ⅱa Study of HMPL-A251 in Participants With Advanced or Metastatic HER2-expressing Solid Tumors · condition mapped ALIAS · 6,088 trials mapped (1,991 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07262619Phase 1/Phase 2 · recruiting EIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) Tumors · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07415031Phase 2 · recruiting A Solid Tumor Study for Long Term Treatment of Cancer Patients Who Participated in Adagrasib Studies · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07522073Phase 3 · recruiting A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07545356Phase 1 · recruiting A Study of KIVU-305 in Participants With Locally Advanced or Metastatic Solid Tumors · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07682870Phase 1/Phase 2 · recruiting A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of VG2025 Intravenous Injection in Subjects With Advanced Solid Tumors · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Malignant Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07763652Phase 1 · recruiting A Study of BL-ARC002 in Patients With Locally Advanced or Metastatic Gastrointestinal Tumors and Other Solid Tumors · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07772934Phase 1/Phase 2 · not yet recruiting VBC117First-in-Human Trial of VBC117 in Participants With Advanced Malignant Solid Tumors · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07830667Phase 1/Phase 2 · not yet recruiting A Phase 1/2 Study of CBX-12 in Children, Adolescents, or Young Adults With Solid Tumors That Have Come Back After Treatment or Are Difficult to Treat · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Childhood Malignant Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07833085NA · not yet recruiting CAIX-targeted PET/CT in Solid Tumors · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Malignant Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07833657Phase 2 · not yet recruiting Combined Intrathecal and Systemic Therapy With Trastuzumab Rezetecan for Leptomeningeal Metastases · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07833735Phase 1/Phase 2 · not yet recruiting A Study to Evaluate the Safety, Tolerability, Pharmacokinetic Profile, and Preliminary Efficacy of SYS6043 ± Bevacizumab ± Chemotherapy in Participants With Advanced Solid Tumors · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07834359Phase 1 · not yet recruiting A Study of HS-20197 in Participants With Advanced Solid Tumors · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00801151Phase 1 · terminated Vorinostat in Combination With Vinorelbine in Patients With Advanced Cancer · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Malignant Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02520713active not recruiting The iCat2, GAIN (Genomic Assessment Informs Novel Therapy) Consortium Study · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Childhood Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03698994Phase 2 · active not recruiting Ulixertinib in Treating Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With MAPK Pathway Mutations (A Pediatric MATCH Treatment Trial) · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Malignant Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04513444Phase 2 · active not recruiting Interest of Medical Hypnosis in Anxious Patients Treated by Radiotherapy · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04827810Phase 1 · suspended A Phase I Safety and Pharmacokinetic Study of Gamitrinib Administered Intravenously to Patients With Advanced Cancer · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04977167Phase 1 · completed Clinical Trial of HG146 Administered to Subjects With Advanced Solid Tumors or Lymphoma · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05259709Phase 1 · recruiting A Study of ImmunoPet Imaging Using 89Zr-DFO-REGN5054 in Adult Participants With Solid Cancers Treated With Cemiplimab · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06005740Phase 1 · active not recruiting A Phase 1, First in Human Study of TORL-4-500 in Patients With Advanced Cancer · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06169579Phase 1 · enrolling by invitation An Open-label, Phase 1 Study to Determine the Maximum Tolerated Dose of ND-003 in Patients With Advanced Solid Cancers · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06260514Phase 1 · recruiting Study of APR-1051 in Patients With Advanced Solid Tumors · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06717750Phase 1 · recruiting A Study of CSCJC3456 in Patients With Advanced Malignant Tumors · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Malignant Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06736379Phase 1 · recruiting Intratumoral Delivery of Viral Replicon (saRNA) Particles Expressing IL-12 in Head and Neck Cancer · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07111546Phase 2 · recruiting A Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumours[Substudy 02(BTC&HCC)] · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07629960Phase 1/Phase 2 · recruiting A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07639905Phase 1 · completed A Clinical Study Comparing the Bioavailability of HRS-2189 Tablets · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Malignant Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07744152Phase 1 · recruiting A Study to Test How Well Different Doses of BI 3822971 Are Tolerated by People With Advanced Cancer (Solid Tumours) · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07830199Phase 1 · not yet recruiting A Clinical Study of SHR-4595 Injection in Patients With Advanced Solid Tumors to Evaluate Safety, Tolerability and Pharmacokinetics · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04439253Phase 2 · active not recruiting Testing Crizotinib as a Potential Targeted Treatment in Cancers With ROS1 Genetic Changes (MATCH-Subprotocol G) · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Malignant Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04693468Phase 1 · recruiting Talazoparib and Palbociclib, Axitinib, or Crizotinib for the Treatment of Advanced or Metastatic Solid Tumors, TalaCom Trial · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Malignant Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05052255Phase 1/Phase 2 · terminated RVU120 (SEL120) in Patients With Relapse/Refractory Metastatic or Advanced Solid Tumors · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05267626Phase 1/Phase 2 · recruiting Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05863052active not recruiting Analyzing Clinical Outcomes and Genomic Data of American Indian Patient Population · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06088472Phase 1 · active not recruiting TIL Injection for the Treatment of Metastatic or Recurrent Solid Tumors · condition mapped ALIAS · 6,088 trials mapped (1,991 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06398418Phase 1 · recruiting R-5780-01 In Combination With PD-1 Checkpoint Inhibitors (Checkpoint Protein on Immune Cells Called T Cells) in Patients With Solid Tumors · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06563375Phase 1 · recruiting Phase 1 Dose Escalation and Dose Expansion Trial of NP-101 in Patients With Solid Tumors · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06859762Phase 1 · recruiting A First-in-Human Study of YL217 in Patients With Advanced Solid Tumors · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07159126Phase 1 · recruiting A Study of DS3610a in Participants With Advanced Solid Tumor · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07396584Phase 1/Phase 2 · recruiting HMPL-A580 in Participants With Advanced or Metastatic Solid Tumor · condition mapped ALIAS · 6,088 trials mapped (1,991 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07435038Phase 1/Phase 2 · recruiting Study of BPI-572270 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07667842Phase 1 · recruiting Study of D3L-002 in Subjects With Advanced Solid Tumors · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07827144Phase 1 · not yet recruiting A Study to Test How Well Different Doses of BI 4060107 Are Tolerated by People With Advanced Cancer (Solid Tumours) · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03447483NA · completed Cohort Study: Modelling Toxicity Processing in Patients Treated by Immunotherapy (MOTIVATE). · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03486873Phase 3 · recruiting Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587) · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03585465Phase 1/Phase 2 · terminated Nivolumab in Combination With Metronomic Chemotherapy in Paediatrics Refractory / Relapsing Solid Tumors · condition mapped ALIAS · 6,088 trials mapped (1,991 active) | — | — | Childhood Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04083976Phase 2 · completed A Study of Erdafitinib in Participants With Advanced Solid Tumors and Fibroblast Growth Factor Receptor (FGFR) Gene Alterations · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04242095recruiting Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects · condition mapped ONTOLOGY_EXACT · 6,088 trials mapped (1,991 active) | — | — | Malignant Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04870788NA · active not recruiting Mindfulness-Based Intervention for Latino Cancer Patients and Their Caregivers · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Malignant Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04998422Phase 1 · recruiting A Study of HG381 Administered to Patients With Advanced Solid Tumors · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05007782Phase 1 · active not recruiting Study of Denikitug (GS-1811) Given Alone or With Zimberelimab in Adults With Advanced Solid Tumors · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06605222Phase 1/Phase 2 · recruiting A Trial of SHR-7787 Injection in Patients With Advanced Solid Tumors · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06953323Phase 1/Phase 2 · recruiting A Phase I/II Study of WJB001 Combination Therapy on Safety and Efficacy for Advanced Solid Tumors · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06987058Phase 2 · enrolling by invitation RVU120 Rollover Study · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07109726Phase 1/Phase 2 · recruiting A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07172802Phase 1/Phase 2 · recruiting A Study of GI-108, an Anti-CD73-IgG4 Fc-IL-2v Bispecific Fusion Protein, as Monotherapy in Patients With Advanced or Metastatic Solid Tumors · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07349537Phase 1 · recruiting Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07545291NA · not yet recruiting A Spiritual Health Intervention (PATH) for Improving Spiritual, Religious and Emotional Distress in Cancer Patients · condition mapped ONTOLOGY_EXACT · 6,088 trials mapped (1,991 active) | — | — | Malignant Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07576725Phase 2 · not yet recruiting Low Dose, Reduced Frequency Nivolumab for the Treatment of Unresectable or Metastatic Cancer, AFFORD IO Trial · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Malignant Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07639450Phase 1/Phase 2 · recruiting N-3C01 Monotherapy and Combination With PD-(L)1 Inhibitors in Advanced Solid Tumors · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Malignant Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07826585Phase 1 · active not recruiting Treatment of Patients With Advanced Solid Tumors Using CRTKVA11-03 TCR-T Cell Injection · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02974738Phase 1 · active not recruiting A Trial of Belzutifan (PT2977, MK-6482) Tablets In Patients With Advanced Solid Tumors (MK-6482-001) · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04940299Phase 2 · active not recruiting Tocilizumab, Ipilimumab, and Nivolumab for the Treatment of Advanced Melanoma, Non-Small Cell Lung Cancer, or Urothelial Carcinoma · condition mapped ONTOLOGY_EXACT · 6,088 trials mapped (1,991 active) | — | — | Malignant Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05641961NA · active not recruiting Mobile App to Help Survivors of Childhood Cancer Navigate Long-Term Follow-Up Care · condition mapped ONTOLOGY_EXACT · 6,088 trials mapped (1,991 active) | — | — | Malignant Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05786924Phase 1/Phase 2 · recruiting Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06233942Phase 1 · recruiting Phase 1a/1b First-in-Human Study of BG-C9074 Alone and in Combination With Other Anticancer Therapies in Patients With Advanced Solid Tumors · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06566079Phase 1/Phase 2 · recruiting Study of ISM6331 in Participants With Advanced/Metastatic Mesothelioma or Other Advanced Solid Tumors · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06606990Phase 1 · recruiting Testing How the Body Responds to the Drug CX-5461 (Pidnarulex) in Patients With Metastatic Solid Cancers · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Malignant Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06873555Phase 1/Phase 2 · recruiting A Study of DC05F01 in Chinese Patients With Recurrent/Refractory Ovarian Cancer and Other Advanced Solid Tumors · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07023731Phase 1/Phase 2 · active not recruiting A Study to Evaluate ARV-806 in Adults With Advanced Cancer That Has the KRAS G12D Mutation · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Malignant Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07184294NA · recruiting Different Types of Massage Therapy to Reduce Anxiety During Chemotherapy Infusion in Patients With Cancer · condition mapped ONTOLOGY_EXACT · 6,088 trials mapped (1,991 active) | — | — | Malignant Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07297160Phase 1 · withdrawn CD70.CAR for CD70+ Lymphoma, Myeloma and Solid Tumors · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07492680Phase 2 · recruiting A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5) · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01303341Phase 1 · active not recruiting Riluzole and Sorafenib Tosylate in Treating Patients With Advanced Solid Tumors or Melanoma · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Malignant Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02453620Phase 1 · active not recruiting Entinostat, Nivolumab, and Ipilimumab in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery or Locally Advanced or Metastatic HER2-Negative Breast Cancer · condition mapped ONTOLOGY_EXACT · 6,088 trials mapped (1,991 active) | — | — | Malignant Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03804255withdrawn Assessment of Current Biomarker Testing Practices for Common Solid Cancers in Precision Oncology in the Community Setting · condition mapped ONTOLOGY_EXACT · 6,088 trials mapped (1,991 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04165772Phase 2 · recruiting Study of Induction PD-1 Blockade in Subjects With Locally Advanced Mismatch Repair Deficient Solid Tumors · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04585750Phase 1/Phase 2 · recruiting The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE) · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05230186completed A Tissue Collection Study in Patients Who Respond to Immune Checkpoint Inhibitors to Identify Targets of Tumor-Reactive T Cells. · condition mapped ALIAS · 6,088 trials mapped (1,991 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05495295Phase 1 · active not recruiting First-in-human Trial of PhOx430, a First-in-class Acetylglucosaminyltransferase V Inhibitor, in Advanced Solid Tumours · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |